| abstract |
A pharmaceutical composition for use for the prophylaxis and treatment of nonalcoholic fatty liver (NAFLD), simple nonalcoholic hepatic steatosis, nonalcoholic steatohepatitis (NASH), nonalcoholic liver fibrosis, or nonalcoholic liver cirrhosis comprising , as an active principle, a 1,4-benzoxacin compound represented by the formula (I): ** (See formula) ** or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier. |